BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/09/2015

FDA Clears Way for Abbreviated New Drug Applications for GLUCAGON (Glucagon Hydrochloride) for Injection

The FDA has determined that GLUCAGON (glucagon hydrochloride) for injection, equivalent to 1 milligram base/vial and equivalent to 10 milligram base/vial, was not withdrawn from sale for reasons of safety or effectiveness, paving the way for the approval of abbreviated new drug applications for this medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →